andrew huberman semaglutide Insights Neuroscientist Andrew Huberman believes GLP-1s

Bimagrumab is another monoclonal antibody that blocks activin type II receptors

Rare but serious complications may include pancreatitis, gallbladder disease, kidney impairment, and potential risks of thyroid tumors , which were identified in animal studies

6) Sleep Apnea: A Novel Approach to Improved Sleep Quality GLP-1 medications, particularly tirzepatide, are garnering attention for their potential in treating sleep apnea, a common sleep disorder characterized by pauses in breathing during sleep

When discussing GLP-1 obesity treatment with patients, it is helpful to frame benefits in terms of overall health gains, not just glucose numbers

Do not use semaglutide if you have medullary thyroid cancer history, and report severe abdominal pain or nausea to your provider immediately